RTX Corp: Form 10-Q for the period ended Sep 30, 2020
Filed with the SEC on Oct 27, 2020 and accepted by EDGAR at Oct 27, 2020, 16:43 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2020-07-01 to 2020-09-30 | $14.75bn | us-gaap:Revenues |
| Revenue | 9 months2020-01-01 to 2020-09-30 | $40.17bn | us-gaap:Revenues |
| Research and development | 3 months2020-07-01 to 2020-09-30 | $642.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2020-01-01 to 2020-09-30 | $1.87bn | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2020-07-01 to 2020-09-30 | $1.40bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2020-01-01 to 2020-09-30 | $4.19bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2020-07-01 to 2020-09-30 | $434.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2020-01-01 to 2020-09-30 | −$2.03bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2020-07-01 to 2020-09-30 | $350.0m | us-gaap:InterestExpense |
| Interest expense | 9 months2020-01-01 to 2020-09-30 | $1.02bn | us-gaap:InterestExpense |
| Income tax | 3 months2020-07-01 to 2020-09-30 | $152.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2020-01-01 to 2020-09-30 | $753.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2020-07-01 to 2020-09-30 | $264.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2020-01-01 to 2020-09-30 | −$3.65bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2020-07-01 to 2020-09-30 | $0.17 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2020-01-01 to 2020-09-30 | −$2.79 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2020-07-01 to 2020-09-30 | $0.17 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2020-01-01 to 2020-09-30 | −$2.79 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2020-07-01 to 2020-09-30 | 1,514,200,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2020-01-01 to 2020-09-30 | 1,311,300,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2020-01-01 to 2020-09-30 | $2.96bn | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 9 months2020-01-01 to 2020-09-30 | $1.17bn | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 9 months2020-01-01 to 2020-09-30 | $2.03bn | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2020-01-01 to 2020-09-30 | $47.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2020-09-30 | $10.00bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2020-09-30 | $43.51bn | us-gaap:AssetsCurrent |
| Total assets | At period end2020-09-30 | $162.40bn | us-gaap:Assets |
| Current liabilities | At period end2020-09-30 | $35.56bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2020-09-30 | $92.29bn | us-gaap:Liabilities |
| Short-term borrowings | At period end2020-09-30 | $228.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2020-09-30 | $68.38bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000101829-20-000071. Last ingested by Listed: Nov 3, 2026, 21:25 ET. Listed shows no prices and gives no investment advice.